JPY 160.0
(-0.63%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 4.12 Billion JPY | 40.59% |
2022 | 2.93 Billion JPY | 26.0% |
2021 | 2.33 Billion JPY | 17.55% |
2020 | 1.98 Billion JPY | -15.18% |
2019 | 2.33 Billion JPY | 13.66% |
2018 | 2.05 Billion JPY | 10.35% |
2017 | 1.86 Billion JPY | -17.19% |
2016 | 2.25 Billion JPY | 4.41% |
2015 | 2.15 Billion JPY | 5.81% |
2014 | 2.03 Billion JPY | 49.32% |
2013 | 1.36 Billion JPY | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 756 Million JPY | -42.68% |
2023 Q3 | 773 Million JPY | -51.32% |
2023 FY | 4.12 Billion JPY | 40.59% |
2023 Q1 | 874 Million JPY | 23.8% |
2023 Q4 | 1.31 Billion JPY | 70.63% |
2023 Q2 | 1.58 Billion JPY | 81.69% |
2022 FY | 2.93 Billion JPY | 26.0% |
2022 Q3 | 800 Million JPY | 4.85% |
2022 Q4 | 706 Million JPY | -11.75% |
2022 Q2 | 763 Million JPY | 14.91% |
2022 Q1 | 664 Million JPY | -4.73% |
2021 Q4 | 697 Million JPY | 30.04% |
2021 Q2 | 539 Million JPY | -3.75% |
2021 Q3 | 536 Million JPY | -0.56% |
2021 FY | 2.33 Billion JPY | 17.55% |
2021 Q1 | 560 Million JPY | -10.83% |
2020 FY | 1.98 Billion JPY | -15.18% |
2020 Q3 | 442 Million JPY | 2.08% |
2020 Q1 | 482 Million JPY | -45.1% |
2020 Q2 | 433 Million JPY | -10.17% |
2020 Q4 | 628 Million JPY | 42.08% |
2019 Q4 | 878 Million JPY | 80.66% |
2019 Q2 | 515 Million JPY | 12.2% |
2019 Q1 | 459 Million JPY | -42.12% |
2019 FY | 2.33 Billion JPY | 13.66% |
2019 Q3 | 486 Million JPY | -5.63% |
2018 Q2 | 364 Million JPY | -16.7% |
2018 Q3 | 466 Million JPY | 28.02% |
2018 Q4 | 793 Million JPY | 70.17% |
2018 FY | 2.05 Billion JPY | 10.35% |
2018 Q1 | 437 Million JPY | 95.32% |
2017 Q1 | 552.49 Million JPY | -8.02% |
2017 FY | 1.86 Billion JPY | -17.19% |
2017 Q4 | 223.73 Million JPY | -38.87% |
2017 Q3 | 366 Million JPY | -8.5% |
2017 Q2 | 400 Million JPY | -27.6% |
2016 Q2 | 541.3 Million JPY | 0.35% |
2016 Q4 | 600.68 Million JPY | 5.44% |
2016 Q3 | 569.68 Million JPY | 5.24% |
2016 Q1 | 539.39 Million JPY | -21.81% |
2016 FY | 2.25 Billion JPY | 4.41% |
2015 FY | 2.15 Billion JPY | 5.81% |
2015 Q4 | 689.81 Million JPY | 19.86% |
2015 Q3 | 575.53 Million JPY | 23.13% |
2015 Q2 | 467.4 Million JPY | 10.46% |
2015 Q1 | 423.16 Million JPY | -45.16% |
2014 Q3 | 485.04 Million JPY | 11.05% |
2014 Q1 | 344.19 Million JPY | -42.03% |
2014 FY | 2.03 Billion JPY | 49.32% |
2014 Q4 | 771.56 Million JPY | 59.07% |
2014 Q2 | 436.78 Million JPY | 26.9% |
2013 FY | 1.36 Billion JPY | 0.0% |
2013 Q4 | 593.79 Million JPY | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
DVx Inc. | 3.96 Billion JPY | -4.167% |
Seikagaku Corporation | 16.44 Billion JPY | 74.891% |
Eiken Chemical Co., Ltd. | 13.34 Billion JPY | 69.064% |
Create Medic Co., Ltd. | 4.67 Billion JPY | 11.681% |
PHC Holdings Corporation | 149.66 Billion JPY | 97.241% |
Techno Medica Co., Ltd. | 3.26 Billion JPY | -26.548% |
Rion Co., Ltd. | 10.85 Billion JPY | 61.97% |
Nihon Kohden Corporation | 91.75 Billion JPY | 95.5% |
Fukuda Denshi Co., Ltd. | 47.94 Billion JPY | 91.388% |
Japan Lifeline Co., Ltd. | 19.34 Billion JPY | 78.65% |
Japan Medical Dynamic Marketing, INC. | 11.65 Billion JPY | 64.573% |
3-D Matrix, Ltd. | 5.2 Billion JPY | 20.649% |